David Cheishvili1,EpiMedTech Global, Singapore 409051, Singapore2,HKG Epitherapeutics Ltd., Hong Kong SAR, China3Gerald Bronfman Department of Oncology, McGill University, Montreal H4A 3T2, Canada, Sonia Do Carmo4Department of Pharmacology & Therapeutics, McGill University, Montreal H3G 1Y6, Canada, Filippo Caraci6,Department of Drug and Health Sciences, University of Catania, Catania 95125, Italy7Neuropharmacology and Translational Neurosciences Research Unit, Oasi Research Institute-IRCCS, Troina 94018, Italy, Margherita Grasso7Neuropharmacology and Translational Neurosciences Research Unit, Oasi Research Institute-IRCCS, Troina 94018, Italy, A Claudio Cuello4,Department of Pharmacology & Therapeutics, McGill University, Montreal H3G 1Y6, Canada5Visiting Professor, Department of Pharmacology, Oxford University, Oxford OX13QT, UK, Moshe Szyf1,EpiMedTech Global, Singapore 409051, Singapore2HKG Epitherapeutics Ltd., Hong Kong SAR, China
- 1EpiMedTech Global, Singapore 409051, Singapore
- 2HKG Epitherapeutics Ltd., Hong Kong SAR, China
- 3Gerald Bronfman Department of Oncology, McGill University, Montreal H4A 3T2, Canada
- 4Department of Pharmacology & Therapeutics, McGill University, Montreal H3G 1Y6, Canada
- 5Visiting Professor, Department of Pharmacology, Oxford University, Oxford OX13QT, UK
- 6Department of Drug and Health Sciences, University of Catania, Catania 95125, Italy
- 7Neuropharmacology and Translational Neurosciences Research Unit, Oasi Research Institute-IRCCS, Troina 94018, Italy
* Equal contribution
